CHAN LY: Open Payments
NPI 1932736121 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,190 in 156 payments from 45 companies in 2025. Trend: 2023 $960 · 2024 $1,953 · 2025 $5,190
Food & beverage: $4,921Education: $269
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $820 |
| AstraZeneca Pharmaceuticals LP | 14 | $644 |
| Regeneron Healthcare Solutions, Inc. | 11 | $497 |
| BeOne Medicines USA, Inc. | 15 | $383 |
| Janssen Biotech, Inc. | 8 | $318 |
| Incyte Corporation | 7 | $222 |
| Novartis Pharmaceuticals Corporation | 7 | $177 |
| Merck Sharp & Dohme LLC | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $128 |
| Gilead Sciences, Inc. | 1 | $125 |
Products named: EPKINLY, LIBTAYO, Venclexta, TEVIMBRA, ENHERTU, JAKAFI, RYBREVANT, BRUKINSA.
Industry payments across WA — which companies pay providers there.
